NNNicholas R. Nelson

Nicholas R. Nelson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nicholas R. Nelson has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Development and initial validation of a practical instrument supporting clinical reasoning and self-directed learning

    by Nicholas R. Nelson, Madison Ricco, Robert Hubal, Heidi N. Anksorus, Courtney L. Bradley, Steven Walker, Conan MacDougall, Tina Brock, Denise H. Rhoney

    Practice pointsHistoric instruments for measuring metacognitive traits are not comprehensive and lack validation in clinical reasoning contexts. This limits their practical use by health profession...

  • Open Access

    Identifying stakeholder behaviors for competency-based pharmacy education: A stage 1 behavior change wheel analysis

    by Denise H. Rhoney, Aleda M.H. Chen, Kimberly K. Daugherty, Mariann D. Churchwell, Krisy-Ann Thornby, Nicholas R. Nelson, Erika L. Kleppinger, Dennis Parker, Stephanie L. Sibicky, Tina Brock, et al.


  • A bibliometric analysis describing the global scope of pharmacist roles (2000–2024)

    by Nicholas R. Nelson, Aleda M.H. Chen, Fei Yu, Rebecca Carlson, Krisy-Ann Thornby, Kimberly K. Daugherty, Eunice P. Chung, Mariann D. Churchwell, Stephanie L. Sibicky, Erika L. Kleppinger, et al.

  • A Bibliometric Analysis of Pharmacist‐Delivered Care: Global Trends, Outcomes, and Practice Settings (2000–2024)

    by Krisy‐Ann Thornby, Aleda M. H. Chen, Fei Yu, Rebecca Carlson, Nicholas R. Nelson, Kimberly K. Daugherty, Eunice P. Chung, Mariann D. Churchwell, Stephanie L. Sibicky, Erika L. Kleppinger, et al.

    Background: As the health care landscape evolves rapidly, the demand for an expanded role of pharmacists is also growing. There is ample literature documenting the positive health outcomes of pharmacist‐provided services, independently and in collaborative roles. Bibliometric analysis can aid researchers in understanding patterns within the literature, which could be useful in examining the reported outcomes and how pharmacy currently is and could evolve to meet society's needs. Thus, the objective of this study was to describe reported outcomes of pharmacist interventions in the literature from 2000 to 2024 by: (1) describing study characteristics, (2) mapping co‐occurrence networks of practice settings, (3) identifying commonly used terminology describing patient‐, population‐, and system‐level outcomes, and (4) comparing outcome differences in the top three practice settings. Methods: Using a bibliometric analytical design, a PubMed literature search focused on pharmacist‐related outcomes was conducted. The search results were imported to Covidence (Melbourne, Australia) for title and abstract screening, followed by categorization into preset outcome categories and subcategories. Included studies were analyzed descriptively to explain the scope, pattern, and common terms, while inferential statistics were used to compare differences between practice settings and outcomes. Results: From 6274 initial publications, 1010 were included, covering outcomes at the patient‐level (758; 75%), systems‐level (666; 65.9%), and population‐level (410; 40.6%). Ambulatory care, hospital, and community pharmacy were the top three practice settings identified. While there were varying co‐occurrences based on the practice setting, Clinical Outcomes, Medication Adherence/Compliance, and Patient Education/Patient Counseling were the three most common subcategories of outcomes published. Publications in the topic areas of Health Disparities/Health Equity and Immunization Rates have emerged in recent years. Conclusion: A bibliometric analysis of pharmacist‐related outcomes describes pharmacist involvement in outcome‐based practice at patient, system, and population levels. The research on pharmacist outcomes continues to grow and is clinically focused. Opportunities to address global and system‐level health needs remain.

  • Future‐Proofing Pharmacy: A Stakeholder‐Informed Forecast of Workforce and Education Needs

    by Denise H. Rhoney, Aleda M. H. Chen, Krisy‐Ann Thornby, Nicholas R. Nelson, Kimberly K. Daugherty, Mariann D. Churchwell, Erika L. Kleppinger, Stephanie Sibicky, Dennis Parker, Kelly R. Ragucci, et al.

    Background: Pharmacy education and workforce development are undergoing significant disruption. While national forecasts outline key directions, they lack granularity and stakeholder validation. This study aimed to develop a stakeholder‐informed, data‐driven forecast of pharmacy strategic priorities through 2035. Objectives were: (1) identify key themes shaping pharmacy's future, (2) align these themes with national priorities, and (3) forecast their trajectory and readiness to inform strategic planning. Methods: A mixed‐methods design integrated qualitative analysis of 27 stakeholder focus groups and eight interviews with trend modeling and policy triangulation. Participants ( n = 148) represented students, faculty, preceptors, administrators, professional organizations, payors, interprofessional educators, and transformation leaders. Transcripts were coded using grounded theory and analyzed for themes. Identified themes were aligned with the 2024 American Association of Colleges of Pharmacy and 2024 American Society of Health‐System Pharmacy Forecast reports. Historical emphasis scores (2015–2024) were modeled using linear regression to project thematic growth through 2035. Each theme was rated for system readiness based on stakeholder insight and national preparedness indicators. Results: Ten core themes emerged: Workforce Shortages/Accessibility, Digital Health/Technology, Competency‐Based Education (CBE), Public Health/Prevention, Medication Safety/Optimization, Interprofessional Collaboration, Patient‐Centered Care, Leadership/Advocacy, Professional Identity/Perception, and Business/Financial Acumen. Convergent themes like Workforce Shortages, Public Health, and Medication Safety were validated by national forecasts and reflected high stakeholder urgency. Digital Health and CBE showed the steepest forecasted growth slopes but were marked by low readiness. A strategic prioritization matrix was developed to guide policy and curricular responses based on urgency, growth, and readiness. Conclusions: This study offers a novel, future‐facing framework to guide the transformation of pharmacy education and workforce strategy. High‐priority, low‐readiness themes require urgent investment. Strategic scaffolds such as leadership, identity, and business acumen, though underemphasized, are critical to sustaining innovation. Pharmacy must reimagine itself as a lifelong, adaptable profession, equipped not only to respond to change but to lead it.


  • A unifying vision for pharmacy: Defining professional identity through stakeholder perspectives

    by Denise H. Rhoney, Kimberly K. Daugherty, Aleda M.H. Chen, Mariann Churchwell, Stephanie Sibicky, Krisy-Ann Thornby, Nicholas R. Nelson, Erika L. Kleppinger, Dennis Parker, Kelly R. Ragucci, et al.


  • The Hidden Architecture of Inertia: Stakeholder Perspectives on the Most Pressing Challenges in Pharmacy Education

    by Denise H. Rhoney, Kimberly K. Daugherty, Aleda M.H. Chen, Erika L. Kleppinger, Mariann D. Churchwell, Krisy-Ann Thornby, Nicholas R. Nelson, Stephanie L. Sibicky, Dennis Parker, Kelly R. Ragucci, et al.


  • From Strength to Struggle: Stakeholder Insights into the Readiness of Tomorrow’s Pharmacists

    by Denise H. Rhoney, Kimberly K. Daugherty, Aleda M.H. Chen, Nicholas R. Nelson, Krisy-Ann Thornby, Erika L. Kleppinger, Mariann D. Churchwell, Stephanie L. Sibicky, Dennis Parker, Kelly R. Ragucci, et al.


  • Pharmacy Is an Applied Discipline: The Baumkuchen Layer Model of Curriculum Design

    by Denise H. Rhoney, Nicholas R. Nelson, Robert Hubal, Misty Stutz, Amanda H. Corbett, Scott Singleton, Cindy D. Stowe


  • Open Access

    Impact of artificial intelligence on future clinical pharmacy research and scholarship

    by Alexandre Chan, William L. Baker, Daniel Abazia, Jerry Bauman, C. Lindsay DeVane, Kellie J. Goodlet, Natalie Hall, James Kevin Hicks, Ellen Jones, Chi‐Hua Lu, et al.

    Almost every facet of modern biomedical research involves artificial intelligence (AI). This ACCP commentary forecasts the role of AI in clinical pharmacy research and scholarship. The potential benefits/opportunities together with the limitations/challenges of AI are reviewed for stages of the scientific method including (1) developing the research question(s), study design, and execution; (2) data analysis; and (3) reporting and dissemination of clinical pharmacy research. Benefits and opportunities of AI in clinical pharmacy research include streamlining hypothesis generation and facilitating study design, overcoming limitations of traditional statistical analysis techniques, facilitating manuscript development and dissemination, and expediting peer review. Limitations and challenges of AI include the introduction of biases in subject recruitment; generation of false information, also known as “AI hallucinations”; concern of “black box” analyses that are difficult to validate; potential legal liabilities; lack of accountability; and the need for investigators to ensure the accuracy and integrity of AI‐generated content. In summary, rapid progress of AI capabilities has great potential to revolutionize and accelerate clinical pharmacy research and scholarship; however, it is also imperative to recognize and mitigate the challenges and limitations introduced by AI.